Clinical Trial: Intravenous Immunoglobulins for Post-Polio Syndrome

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: Postpolio syndrome is a condition that affects many polio survivors years after the acute infection and causes symptoms to increase or new symptoms to develop. Proinflammatory cytokine production within the central nervous system (CNS) indicates an underlying inflammatory process, amenable to immunomodulatory therapy. In this study the investigators sought to confirm that antiinflammatory treatment with intravenous immunoglobulin improves the disease.

Detailed Summary:
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Current Primary Outcome: SF-36 physical component [ Time Frame: Baseline; 2 and 4 months after treatment ]

Original Primary Outcome: SF-36 physical component

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Azienda Ospedaliera Universitaria Integrata Verona

Dates:
Date Received: February 17, 2012
Date Started: January 2008
Date Completion:
Last Updated: February 23, 2012
Last Verified: February 2012